Cargando…
High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome
Intronic splicing silencer N1 (ISS-N1) located within Survival Motor Neuron 2 (SMN2) intron 7 is the target of a therapeutic antisense oligonucleotide (ASO), nusinersen (Spinraza), which is currently being used for the treatment of spinal muscular atrophy (SMA), a leading genetic disease associated...
Autores principales: | Ottesen, Eric William, Luo, Diou, Singh, Natalia Nikolaevna, Singh, Ravindra Narayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395096/ https://www.ncbi.nlm.nih.gov/pubmed/34445083 http://dx.doi.org/10.3390/ijms22168378 |
Ejemplares similares
-
Internal Introns Promote Backsplicing to Generate Circular RNAs from Spinal Muscular Atrophy Gene
por: Luo, Diou, et al.
Publicado: (2022) -
High-affinity RNA targets of the Survival Motor Neuron protein reveal diverse preferences for sequence and structural motifs
por: Ottesen, Eric W, et al.
Publicado: (2018) -
ISS-N1 makes the First FDA-approved Drug for Spinal Muscular Atrophy
por: Ottesen, Eric W.
Publicado: (2017) -
Human Survival Motor Neuron genes generate a vast repertoire of circular RNAs
por: Ottesen, Eric W, et al.
Publicado: (2019) -
Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members
Publicado: (1994)